tiprankstipranks
Advertisement
Advertisement

Vimta Labs moves to clean up shareholder records as IEPF transfers, KYC drive and special demat window advance

Story Highlights
  • Vimta Labs warns that unclaimed FY19 dividends and related shares will shift to IEPF if investors fail to update details and claim them in time.
  • The company opens a SEBI-backed window and a 100-day Saksham Niveshak drive to dematerialise physical shares, update KYC, and curb IEPF transfers.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Vimta Labs moves to clean up shareholder records as IEPF transfers, KYC drive and special demat window advance

Meet Samuel – Your Personal Investing Prophet

Vimta Labs Limited ( (IN:VIMTALABS) ) has shared an update.

Vimta Labs has notified shareholders that unclaimed final dividends for FY 2018-19 and the corresponding equity shares will be transferred to the Investor Education and Protection Fund if not claimed by the statutory deadline, with detailed shareholder lists and procedures available on its website. The company outlines the impact on both physical and demat holders, urges prompt KYC, bank and contact detail updates to ensure electronic dividend payments, and explains how investors can reclaim dividends and shares from the IEPF after transfer.

The company is also opening a SEBI-mandated special window until February 4, 2027 for investors who bought physical shares before April 1, 2019 to regularise transfers and dematerialise holdings subject to documentation rules. In parallel, Vimta has launched the “Saksham Niveshak” 100-day campaign to drive KYC and nomination updates, help investors recover unpaid dividends, and reduce the risk of further funds and shares being moved to the IEPF, signalling a push toward cleaner records and fully electronic shareholder servicing ahead of its AGM through virtual means.

More about Vimta Labs Limited

Vimta Labs Limited is an Indian life sciences company based in Hyderabad that provides analytical testing and related laboratory services to sectors such as pharmaceuticals and biotechnology. The company is listed on BSE and NSE and serves a broad shareholder base, including investors holding both physical and dematerialised equity shares.

Average Trading Volume: 11,379

Technical Sentiment Signal: Buy

Current Market Cap: 20.43B INR

For a thorough assessment of VIMTALABS stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1